Author's posts
Inside Nemours Children's $430M investment in Florida and Delaware
Nemours Children’s Health is investing $300 million in central Florida over the next four years and $130 million in Delaware in 2025.
Michigan health system appoints global ambassador
Flint, Mich.-based Insight Health System has named Dr. Maliha Hashmi, a leader in AI-driven precision care, health equity and wellness advocacy, as its first global ambassador.
President-elect Trump taps HHS landing team leader: Politico
President-elect Donald Trump has selected John Brooks as the leader of his HHS landing team, Politico reported Dec. 17.
Advocate's $1B investment in Chicago: 5 funding details
Advocate Health Care on Dec. 17 unveiled plans to expand on Chicago’s South Side with $1 billion invested in new facilities and services.
Congress' healthcare package: Key wins for hospitals, telehealth and physician pay
Lawmakers have unveiled a sweeping government funding deal containing a significant healthcare package that would extend Medicare telehealth flexibilities, increase physician reimbursement rates and implement new regulations targeting pharmacy benefit …
Aspirus Health's plan to fill gap left by HSHS hospital closures moves forward
Chippewa Falls (Wis.) City Council has approved Aspirus Health’s proposed location for a new hospital in the city to fill a gap left in the region from the closure of two hospitals earlier this year, WEAU reported Dec. 17.
Tufts Medicine names SVP of revenue cycle
Burlington, Mass.-based Tufts Medicine has named Rachel Verville senior vice president of revenue cycle, according to a Dec. 17 post on her LinkedIn page.
Google, Suki partner on clinical assistant
Suki and Google Cloud are advancing clinical support technology to include patient summaries and a question-and-answer functionality.
New York cancer center opens $98M cell, gene therapy hub
Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center opened a $98 million cell and gene therapy hub aimed at growing the center’s capabilities for cancer cell therapy research.
2023 chemotherapy shortage did not affect mortality rates: 6 study notes
A 2023 shortage of the generic platinum-based chemotherapy drugs cisplatin and carboplatin had no effect on cancer mortality rates, according to a study published Dec. 3 in the Journal of the National Cancer Institute.
